Over half of patients with controlled type 2 diabetes have many more tests than is currently recommended by national guidelines, and this has been associated with overtreatment of the condition, suggests a large US study published in The BMJ.
Overtreatment is a concern because it can lead to higher costs in the healthcare system, a concern due to runaway expenses causes by the Affordable Care Act, called Obamacare by officials and the public.
Since Type 2 diabetes is usually caused by lifestyle rather than a predisposition, "patients and doctors should question the value of routine tests."